Synaptics Faces Investigation Amid ON Semiconductor Acquisition
Synaptics Inc's stock has dropped 3.02% as it hits a 20-day low amid broader market declines, with the Nasdaq-100 down 1.07% and the S&P 500 down 0.16%.
The recent acquisition of Synaptics by ON Semiconductor for nearly $7 billion has raised concerns, as Ademi LLP is investigating potential breaches of fiduciary duty related to the transaction. The deal, which values Synaptics shareholders at a 19% premium, has sparked scrutiny over the board's responsibilities and the limitations on competing bids, potentially affecting shareholder trust.
This investigation could have significant implications for Synaptics, as it may lead to legal disputes and impact the company's reputation. Investors will be closely monitoring the situation as it unfolds, particularly in light of the ongoing market volatility.
Trade with 70% Backtested Accuracy
Analyst Views on SYNA
About SYNA
About the author

- Investigation Background: Halper Sadeh LLC is investigating several companies, including Synaptics, Iridium Communications, and Bio-Techne, for potential violations of federal securities laws and breaches of fiduciary duties, which may affect shareholder rights.
- Synaptics Transaction: The deal between Synaptics and onsemi involves exchanging each Synaptics share for 1.350 shares of onsemi common stock, potentially limiting superior competing offers and impacting shareholder options.
- Iridium Transaction: Iridium Communications is selling for $27.00 in cash per share and shares of Rocket Lab common stock calculated via an exchange ratio, prompting shareholders to consider the implications of the transaction terms on their rights.
- Bio-Techne Transaction: Bio-Techne is being sold to Merck KGaA for $73.00 per share in cash, and Halper Sadeh LLC may seek increased compensation and additional disclosures for shareholders regarding the transaction.
- Acquisition Deal: ON Semiconductor is acquiring Synaptics in an all-stock transaction valued at approximately $7 billion, marking its largest acquisition to date, with Synaptics shareholders receiving 1.350 shares of Onsemi for each Synaptics share, representing a 19% premium based on the 10-day volume-weighted average closing prices.
- Market Expansion: This acquisition is expected to expand ON Semiconductor's addressable market by $30 billion to $243 billion by 2030, highlighting the company's strong growth potential in the physical AI sector.
- Analyst Rating: Cantor Fitzgerald raised ON Semiconductor's price target from $100 to $110 while maintaining a
- Price Target Adjustments: Mizuho lowered On Semiconductor's price target from $150 to $125 while raising Synaptics' target from $128 to $170, reflecting differing expectations for the future performance of both companies.
- Acquisition Impact: On Semiconductor announced last week its intention to acquire Synaptics in an all-stock deal worth $7 billion, and although this news caused ON's stock to drop approximately 21% post-announcement, analysts view this as a good entry point with expectations for accelerating trends in the second half.
- Market Demand Recovery: Analysts noted that ON is likely to benefit from a recovery in demand for WiFi connectivity, system-on-chip (SoC), and robotics technologies, particularly with AI data center revenues increasing by 100% year-over-year to about $500 million, representing 7% of total revenue.
- Potential Risks: Despite the optimistic outlook for ON, analysts highlighted potential headwinds for Synaptics due to exposure in the PC and consumer electronics markets, especially as Xiaomi has cut its 2026 handset shipment forecast by 30%, which could pose downside risks for SYNA.
- Investigation Background: Halper Sadeh LLC is investigating companies such as Iridium Communications Inc., Theravance Biopharma, Inc., Synaptics Incorporated, and Bio-Techne Corporation for potential violations of federal securities laws and breaches of fiduciary duties, which may affect shareholder rights.
- Transaction Details: Iridium Communications Inc. is set to be sold for $27.00 per share in cash and Rocket Lab stock, while Theravance Biopharma, Inc. is priced at $17.00 per share, Synaptics Incorporated at 1.350 shares of onsemi stock per share, and Bio-Techne Corporation at $73.00 per share in cash.
- Shareholder Rights Protection: Halper Sadeh LLC encourages shareholders to contact the firm to discuss their rights and options at no cost, aiming to provide legal support and potential compensation for affected investors.
- Legal Service Commitment: The law firm commits to handling cases on a contingent fee basis, meaning shareholders will not be responsible for upfront legal fees or expenses, ensuring that more investors can access legal assistance.
- Market Sell-Off Impact: Chip stocks, particularly Nvidia, ON Semiconductor, and Intel, have faced significant declines this week due to increasing doubts about the returns on AI spending, putting pressure on the entire sector and requiring investors to navigate market volatility cautiously.
- Nvidia's Strong Performance: Despite an 18% drop from its 52-week high, Nvidia reported an 85% year-over-year revenue increase to $81.6 billion in Q1 2027, with data center revenue soaring 92% to $75.2 billion, highlighting its robust position in the AI market.
- ON Semiconductor Acquisition Risks: ON Semiconductor's stock plummeted 23% following its announcement of a $7 billion acquisition of Synaptics, raising concerns about shareholder dilution and integration risks, even as its Q1 revenue grew 5% year-over-year, which may impact its stock performance in the short term.
- Intel's Turnaround Challenges: Intel's stock has rebounded to around $128 from a 52-week low, with Q1 revenue up 7% to $13.6 billion, and securing Tesla as a major customer; however, it still faces profitability issues, making its turnaround uncertain and requiring investor vigilance.
- Nvidia Valuation Drop: Nvidia now trades at about 29 times earnings, significantly below its average over the past year, despite reporting an 85% year-over-year revenue increase to $81.6 billion in Q1 2027, with data center revenue soaring 92% to $75.2 billion, indicating strong performance in AI; however, market doubts about the sustainability of AI spending may lead to further stock volatility.
- ON Semiconductor Acquisition Risks: ON Semiconductor's announcement of a $7 billion all-stock acquisition of Synaptics triggered a more than 23% drop in its stock price in one day, although its Q1 revenue rose 5% year-over-year, signaling a recovery, the dilution effect of the acquisition and integration risks have unsettled investors, necessitating close monitoring of future performance.
- Intel Turnaround Success: Intel's stock has surged from a 52-week low of $19 to over $141, with Q1 revenue increasing 7% to $13.6 billion; however, despite reporting non-GAAP earnings of $0.29, its foundry business still lost $2.4 billion, indicating that the turnaround is not fully realized, and investors should remain cautious.
- Market Sentiment Impact: The entire chip sector has faced sell-offs due to concerns over AI spending, and while Nvidia, ON Semiconductor, and Intel each face unique challenges, this situation presents investors with opportunities to buy quality stocks at discounted prices, particularly as Nvidia maintains a competitive edge in a rapidly growing market.










